Affiliations: Universita Campus Biomedico Area di geriatria Via Alvaro del Portillo 21 00128 Roma.
Area di Geriatria, Centro Per la Salute dell'Anziano, Università Campus Biomedico, Roma, Italy
References: Mannino, D.M., Buist, A.S., Global burden of COPD: Risk factors, prevalence, and future trends (2007) Lancet, 370 (9589), pp. 765-773. , DOI 10.1016/S0140-6736(07)61380-4, PII S014067360761380
Murray, C.J., Lopez, A.D., Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study (1997) Lancet, 349, pp. 1498-1504
Fabbri, L., Ferrari, R., Chronic disease in the elderly: Back to the future of Internal Medicine (2006) Breath, 3, pp. 40-49
Barnes, P.J., Celli, B.R., Systemicmanifestations and comorbidities of COPD (2009) Eur Respir J, 33, pp. 1165-1185
Antonelli Incalzi, R., Nozzoli, C., Roversi, P., Fabbri, L.M., (2010) Definizione Ed Aspetti Sistemici, , Progetto mondiale BPCO. Gruppi di lavoro per l'adattamento italiano
Sin, D.D., Wu, L., Man, S.F., The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature (2005) Chest, 127, pp. 1952-1959
Anthonisen, N.R., Connett, J.E., Kiley, J.P., Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study (1994) JAMA, 272, pp. 1497-1505
Hole, D.J., Watt, G.C., Davey-Smith, G., Hart, C.L., Gillis, C.R., Hawthorne, V.M., Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study (1996) BMJ, 313, pp. 711-715
MacNee, W., Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease (2005) Proceedings of the American Thoracic Society, 2 (1), pp. 50-60. , DOI 10.1513/pats.200411-056SF
Hunninghake, G.W., Crystal, R.G., Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers (1983) Am Rev Respir Dis, 128, pp. 833-838
Rennard, S.I., Inflammation and repair processes in chronic obstructive pulmonary disease (1999) Am J Respir Crit Care Med, 160, pp. S12-S16
Rahman, I., MacNee, W., Role of oxidants/antioxidants in smoking-induced lung diseases (1996) Free Radical Biology and Medicine, 21 (5), pp. 669-681. , DOI 10.1016/0891-5849(96)00155-4
Jeffery, P.K., Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture (2000) Chest, 117, pp. 251S-260S
Vernooy, J.H., Küçükaycan, M., Jacobs, J.A., Local and systemic inflammation in patients with chronic obstructive pulmonary disease: Soluble tumor necrosis factor receptors are increased in sputum (2002) Am J Respir Crit Care Med, 166, pp. 1218-1224
Celli, B.R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A.S., Calverley, P.M.A., ZuWallack, R., Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper (2004) European Respiratory Journal, 23 (6), pp. 932-946
Pauwels, R.A., Buist, A.S., Calverley, P.M.A., Jenkins, C.R., Hurd, S.S., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary (2001) American Journal of Respiratory and Critical Care Medicine, 163 (5), pp. 1256-1276
Fabbri, L.M., Rabe, K.F., From COPD to chronic systemic inflammatory syndrome? (2007) Lancet, 370, pp. 797-799
Bon, J.M., Leader, J.K., Weissfeld, J.L., The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease (2009) PLoS One, 4, pp. e6865
Roy, K., Smith, J., Kolsum, U., Borrill, Z., Vestbo, J., Singh, D., COPD phenotype description using principal components analysis (2009) Respir Res, 10, p. 41
Sin, D.D., Man, S.F., Marciniuk, D.D., The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease (2008) Am J Respir Crit Care Med, 177, p. 1207. , ABC (Advair, Biomarkers in COPD) Investigators
Calder, P.C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases (2006) Am J Clin Nutr, 83, pp. 1505S-1519S
Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., James, M.J., The effect on human tumor necrosis factor alpha and interleukin 1beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil (1996) American Journal of Clinical Nutrition, 63 (1), pp. 116-122
Dentener, M.A., Creutzberg, E.C., Schols, A.M.W.J., Mantovani, A., Van'T, V.C., Buurman, W.A., Wouters, E.F.M., Systemic anti-inflammatory mediators in COPD: Increase in soluble interleukin 1 receptor II during treatment of exacerbations (2001) Thorax, 56 (9), pp. 721-726. , DOI 10.1136/thorax.56.9.721
Aronson, D., Roterman, I., Yigla, M., Kerner, A., Avizohar, O., Sella, R., Bartha, P., Markiewicz, W., Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects (2006) American Journal of Respiratory and Critical Care Medicine, 174 (6), pp. 626-632. , http://ajrccm.atsjournals.org/cgi/reprint/174/6/626.pdf, DOI 10.1164/rccm.200602-243OC
Crawford, D.C., Sanders, C.L., Qin, X., Smith, J.D., Shephard, C., Wong, M., Witrak, L., Nickerson, D.A., Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey (2006) Circulation, 114 (23), pp. 2458-2465. , DOI 10.1161/CIRCULATIONAHA.106.615740, PII 0000301720061205000008
Antonelliincalzi, R., Fuso, L., Serra, M., Basso, S., Carosella, L., Tramaglino, L.M., Pistelli, R., Carbonin, P., Exacerbated chronic obstructive pulmonary disease: A frequently unrecognized condition (2002) Journal of Internal Medicine, 252 (1), pp. 48-55. , DOI 10.1046/j.1365-2796.2002.01005.x
Yanbaeva, D.G., Dentener, M.A., Creutzberg, E.C., Wesseling, G., Wouters, E.F.M., Systemic effects of smoking (2007) Chest, 131 (5), pp. 1557-1566. , DOI 10.1378/chest.06-2179
Sin, D.D., Paul, M.S.F., Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease (2003) Circulation, 107 (11), pp. 1514-1519. , DOI 10.1161/01.CIR.0000056767.69054.B3
Dahl, M., Tybjaerg-Hansen, A., Vestbo, J., Lance, P., Nordestgaard, B.G., Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease (2001) American Journal of Respiratory and Critical Care Medicine, 164 (6), pp. 1008-1011
Watz, H., Waschki, B., Kirsten, A., The metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity (2009) Chest, 136, pp. 1039-1046
Garcia-Aymerich, J., Serra, I., Gómez, F.P., Physical activity and clinical and functional status in COPD (2009) Chest, 136, pp. 62-70
Barr, R.G., Mesia-Vela, S., Austin, J.H.M., Basner, R.C., Keller, B.M., Reeves, A.P., Shimbo, D., Stevenson, L., Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) study (2007) American Journal of Respiratory and Critical Care Medicine, 176 (12), pp. 1200-1207. , http://ajrccm.atsjournals.org/cgi/reprint/176/12/1200, DOI 10.1164/rccm.200707-980OC
Moro, L., Pedone, C., Scarlata, S., Malafarina, V., Fimognari, F., Antonelli-Incalzi, R., Endothelial dysfunction in chronic obstructive pulmonary disease (2008) Angiology, 59 (3), pp. 357-364. , DOI 10.1177/0003319707306141
Eickhoff, P., Valipour, A., Kiss, D., Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease (2008) Am J Respir Crit Care Med, 178, pp. 1211-1218
Ozben, B., Eryüksel, E., Tanrikulu, A.M., Papila-Topal, N., Celikel, T., Başaran, Y., Acute exacerbation impairs endothelial function in patients with chronic obstructive pulmonary disease (2010) Turk Kardiyol Dern Ars, 38, pp. 1-7
Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation
Chronic obstructive pulmonary disease (COPD) is the only chronic disease whose prevalence is increasing. It is the third cause of death wordwide, and it is projected to became the third in about ten years. COPD is strongly associated with cardiovascular diseases: this association is in part explained by risk factors in common (especially smoking), but in the latest years the hypothesis that COPD may cause a systemic inflammatory state, that in turn causes the increased risk of cardiovascular diseases in these patients, is taking over. The aim of this paper is to review the available evidence about the association of COPD with systemic inflammation, and how this is linked with development of cardiovascular diseases.
Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(349 views) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 ViewExport to BibTeXExport to EndNote